Selective anti-HDAC8 inhibitors are known to induce differentiation of NB cells with concomitant induction of NTRK1 [32,50], and HDAC1 in complex with MYCN suppresses NTRK1 expression [51]. The gene discussed is HDAC8; the disease is neuroblastoma.